Transitioning from Miralax BID + Docusate to Linzess

Rationale for Discontinuing Current Regimen

The National Comprehensive Cancer Network (NCCN) guidelines do not recommend docusate for constipation management due to lack of proven benefit 1
The European Society for Medical Oncology (ESMO) lists docusate under "Laxatives generally not recommended in advanced disease" due to inadequate experimental evidence 1
Docusate only works as a surfactant to allow water penetration into stool but does not address the fundamental problem of inadequate bowel motility or secretion 1
Patients on double the standard dose of polyethylene glycol (PEG) may require escalation to second-line secretagogue therapy rather than continuing to increase osmotic laxative doses 2, 3

Discontinue docusate completely, as it provides no therapeutic benefit, and reduce Miralax from BID to once daily (17g) in the evening, then start Linzess 145 mcg once daily in the morning, at least 30 minutes before breakfast on an empty stomach 1, 2
If constipation is adequately controlled, attempt to discontinue Miralax entirely, maintaining only Linzess 145 mcg daily 2
If significant diarrhea develops, reduce Linzess to 72 mcg daily, the lower FDA-approved dose for chronic idiopathic constipation 2

Linaclotide, the active ingredient in Linzess, enhances intestinal secretions through a different mechanism than osmotic laxatives, increasing both stool frequency and improving stool consistency within the first week of treatment 4, 5
Linzess may provide additional benefit for abdominal pain and bloating that Miralax does not address, as recommended by the American Gastroenterological Association and British Society of Gastroenterology 6, 2, 3

Linzess must be taken on an empty stomach, at least 30 minutes before the first meal of the day, for optimal efficacy, and taking it with food significantly reduces absorption and effectiveness 2, 6
Do not start with Linzess 290 mcg, as this is the IBS-C dose and will cause excessive diarrhea in most patients with chronic idiopathic constipation, instead start with 145 mcg (or 72 mcg in elderly or frail patients) 2
Counsel patients to expect mild diarrhea in the first week, which is usually self-limited and does not require discontinuation unless severe, and document failure of adequate trial of osmotic laxatives for insurance prior authorization 5, 3, 2